An innovative and reliable approach using monocyte-derived hepatocyte-like (MH) cells has demonstrated high sensitivity and specificity in the diagnosis of idiosyncratic drug-induced liver injury (iDILI), according to data presented at the International Digestive Disease Forum (IDDF) organized by the Chinese University of Hong Kong (CUHK).
Vonoprazan, a novel potassium-competitive acid blocker (P-CAB), is at least as effective as proton-pump inhibitors (PPIs) in the treatment of acid-related disorders, according to results of Japanese studies reported at the International Digestive Disease Forum (IDDF) 2019.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Gastroenterology - Malaysia digital copy today!
Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.